According to a recent report by CIDRAP and the CDC, published on November 24, 2025, viral activity is on the rise, and it's ...

Learn what happens to cells inside the nose during an RSV infection, and why infants are so vulnerable to the virus.

The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...

Food and Drug Administration officials have opened a safety review of two injectable drugs used to protect babies and ...

It's once again the time of year for an uptick in illnesses such as colds, the flu, COVID and RSV. Here are the signs and ...

Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems have been reported.

The Centers for Disease Control and Prevention's vaccine advisory committee voted on Thursday to recommend infants receive a newer monoclonal antibody shot for respiratory syncytial virus (RSV). The ...

In a new study, adults 45 and up who got this seasonal virus had a higher risk of major heart issues, especially in the first ...

U.S. regulators are reexamining infant RSV antibody treatments as safety questions surface, prompting new FDA scrutiny of ...

Respiratory syncytial virus, commonly known as RSV, is often associated with cold-like symptoms in young children.

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective ...